ArticleTargeted oncology2024

Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial.

Feride Yılmaz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.